Related Experiment Video
Updated: Jul 18, 2026
08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Reprogramming the host response in bacterial meningitis: how best to improve outcome?
M van der Flier1, S P M Geelen, J L L Kimpen
1Wilhelmina Children's Hospital, Utrecht, The Netherlands. m.vanderflier@lab.azu.nl
Clinical Microbiology Reviews
|July 15, 2003
Summary
Bacterial meningitis remains dangerous despite antibiotics. Modulating the host inflammatory response, not just targeting one mediator, shows promise for improving outcomes and reducing brain injury.
Area of Science:
- Neuroscience
- Immunology
- Infectious Diseases
Background:
- Bacterial meningitis causes significant morbidity and mortality despite antibiotic treatment.
- The host's inflammatory response in the central nervous system contributes to injury.
- Early inflammation attenuation may improve patient outcomes.
Purpose of the Study:
- To review and compare the potential benefits of various adjuvant agents for bacterial meningitis.
- To identify promising therapeutic targets beyond single mediator inhibition.
Main Methods:
- Literature review of animal studies and clinical data on adjuvant therapies for bacterial meningitis.
- Analysis of pathways involved in inflammation and neuronal damage.
- Comparison of single-target inhibition versus multi-mediator modulation.
Main Results:
- Dexamethasone therapy has shown feasibility in reducing neurologic sequelae.
- Inhibiting a single pro-inflammatory mediator is unlikely to be clinically effective.
- Simultaneous modulation of multiple mediators, cytokine combinations, and neuroprotection strategies are promising.
Conclusions:
- Future therapeutic strategies for bacterial meningitis should focus on reprogramming the host inflammatory response rather than single-target inhibition.
- Approaches targeting cytokine combinations, neuronal apoptosis, and brain repair offer significant promise for improved clinical outcomes.
Related Concept Videos
01:31Defense Against Bacterial Pathogens
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
01:28Regulation of Bacterial Virulence
Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
01:24Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...